| Primary |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
13.7% |
| Immunodeficiency Common Variable |
12.9% |
| Myasthenia Gravis |
10.4% |
| Idiopathic Thrombocytopenic Purpura |
6.8% |
| Hypogammaglobulinaemia |
6.4% |
| Product Used For Unknown Indication |
6.2% |
| Guillain-barre Syndrome |
5.8% |
| Kawasaki's Disease |
4.6% |
| Neuropathy Peripheral |
4.2% |
| Primary Immunodeficiency Syndrome |
4.2% |
| Thrombocytopenia |
4.2% |
| Immunodeficiency |
4.0% |
| Dermatomyositis |
3.2% |
| Polyneuropathy |
2.6% |
| Drug Use For Unknown Indication |
2.2% |
| Epistaxis |
2.0% |
| Polymyositis |
2.0% |
| Selective Igg Subclass Deficiency |
1.8% |
| Muscular Weakness |
1.6% |
| Demyelinating Polyneuropathy |
1.4% |
|
| Urticaria |
11.0% |
| Vomiting |
10.5% |
| Pyrexia |
9.3% |
| Haemolysis |
8.0% |
| Infusion Related Reaction |
7.2% |
| Haemolytic Anaemia |
6.3% |
| Tremor |
5.5% |
| Wheezing |
4.6% |
| Meningitis Aseptic |
4.2% |
| Rash |
3.8% |
| Renal Failure |
3.8% |
| Transfusion-related Acute Lung Injury |
3.8% |
| Renal Failure Acute |
3.4% |
| Herpes Simplex Serology Positive |
3.0% |
| Red Blood Cell Spherocytes Present |
3.0% |
| Hepatitis B |
2.5% |
| Nausea |
2.5% |
| Pruritus |
2.5% |
| Respiratory Rate Increased |
2.5% |
| Thrombosis |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
15.0% |
| Primary Immunodeficiency Syndrome |
13.7% |
| Immunodeficiency Common Variable |
8.9% |
| Idiopathic Thrombocytopenic Purpura |
8.2% |
| Premedication |
7.4% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
6.8% |
| Myasthenia Gravis |
6.4% |
| Guillain-barre Syndrome |
5.7% |
| Hypogammaglobulinaemia |
4.6% |
| Kawasaki's Disease |
4.6% |
| Demyelinating Polyneuropathy |
3.4% |
| Drug Use For Unknown Indication |
2.6% |
| Immunodeficiency |
2.3% |
| Epistaxis |
1.8% |
| Autoimmune Disorder |
1.6% |
| Combined Immunodeficiency |
1.6% |
| Thrombocytopenia |
1.6% |
| Dermatomyositis |
1.4% |
| Humoral Immune Defect |
1.2% |
| Multiple Sclerosis |
1.2% |
|
| Hepatitis C Virus Test Positive |
10.3% |
| Drug Intolerance |
9.4% |
| Pyrexia |
8.5% |
| Hepatitis B Positive |
7.7% |
| Tremor |
6.0% |
| Vomiting |
6.0% |
| Drug Ineffective |
5.1% |
| Renal Failure |
5.1% |
| Hepatitis B Surface Antigen Positive |
4.7% |
| Hepatitis B |
4.3% |
| Haemolysis |
3.8% |
| Haemolytic Anaemia |
3.8% |
| Hepatitis A Antibody Positive |
3.4% |
| Hepatitis B Virus Test Positive |
3.4% |
| Infusion Related Reaction |
3.4% |
| Blood Pressure Increased |
3.0% |
| Chest Pain |
3.0% |
| Meningitis Aseptic |
3.0% |
| Respiratory Failure |
3.0% |
| Staphylococcal Infection |
3.0% |
|
| Concomitant |
| Asthma |
28.5% |
| Hypersensitivity |
15.8% |
| Product Used For Unknown Indication |
8.4% |
| Incision Site Pain |
6.6% |
| Prophylaxis |
5.6% |
| Infection |
4.3% |
| Drug Use For Unknown Indication |
3.6% |
| Blood Immunoglobulin G Decreased |
3.3% |
| Chronic Lymphocytic Leukaemia |
3.3% |
| Pregnancy |
3.3% |
| Sinus Headache |
3.3% |
| Immunosuppression |
3.1% |
| Nausea |
2.3% |
| Idiopathic Thrombocytopenic Purpura |
2.0% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.3% |
| Immunodeficiency Common Variable |
1.3% |
| Anxiety |
1.0% |
| Depression |
1.0% |
| Dyspepsia |
1.0% |
| Dyspnoea |
1.0% |
|
| Drug Exposure During Pregnancy |
20.5% |
| Weight Decreased |
9.1% |
| Death |
6.8% |
| Dyspnoea |
6.8% |
| Hepatitis B Positive |
6.8% |
| Biopsy Bone Marrow Abnormal |
4.5% |
| Headache |
4.5% |
| Lung Disorder |
4.5% |
| Pyrexia |
4.5% |
| Thrombocytopenia |
4.5% |
| Urticaria |
4.5% |
| White Blood Cell Disorder |
4.5% |
| Anti-hbc Igg Antibody Positive |
2.3% |
| Autoimmune Thrombocytopenia |
2.3% |
| Cystitis |
2.3% |
| Drug Ineffective |
2.3% |
| Extravascular Haemolysis |
2.3% |
| Failed Induction Of Labour |
2.3% |
| Gastrostomy Tube Insertion |
2.3% |
| Haemolytic Transfusion Reaction |
2.3% |
|
